Stay updated on Surufatinib, Toripalimab & Chemo in 2nd-line CRC Clinical Trial

Sign up to get notified when there's something new on the Surufatinib, Toripalimab & Chemo in 2nd-line CRC Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Surufatinib, Toripalimab & Chemo in 2nd-line CRC Clinical Trial page

  1. Check
    6 days ago
    No Change Detected
  2. Check
    13 days ago
    Change Detected
    Summary
    Revision updated to v3.4.2. Older notices including v3.4.1 and the government funding status notice were removed.
    Difference
    0.5%
    Check dated 2026-02-11T14:19:11.000Z thumbnail image
  3. Check
    21 days ago
    Change Detected
    Summary
    Added a general status notice about government funding and NIH operations, and updated the site software version to v3.4.1. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.5%
    Check dated 2026-02-04T10:40:00.000Z thumbnail image
  4. Check
    28 days ago
    Change Detected
    Summary
    Added a glossary toggle and new metadata labels: 'Last Update Submitted that Met QC Criteria', 'No FEAR Act Data', and 'Revision: v3.4.0'. Removed the previous labels 'Last Update Submitted that met QC Criteria', 'No FEAR Act data', and 'Revision: v3.3.4'.
    Difference
    0.2%
    Check dated 2026-01-28T06:38:16.000Z thumbnail image
  5. Check
    35 days ago
    Change Detected
    Summary
    Key sections including Interventions/Treatment, Outcome Measures, Eligibility Criteria, and Study Record Dates appear to be removed. This reduces visibility into the trial design, endpoints, and enrollment details.
    Difference
    17%
    Check dated 2026-01-21T04:25:48.000Z thumbnail image
  6. Check
    42 days ago
    Change Detected
    Summary
    Page revision updated from v3.3.3 to v3.3.4; no clinical trial data or page content changes were made. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2026-01-14T02:51:50.000Z thumbnail image
  7. Check
    63 days ago
    Change Detected
    Summary
    A dedicated Locations section has been added with Zhejiang listed as the site. The page revision is updated to v3.3.3, and the old Zhejiang Locations entry plus the HHS Vulnerability Disclosure link have been removed.
    Difference
    0.2%
    Check dated 2025-12-23T14:30:41.000Z thumbnail image

Stay in the know with updates to Surufatinib, Toripalimab & Chemo in 2nd-line CRC Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Surufatinib, Toripalimab & Chemo in 2nd-line CRC Clinical Trial page.